STOCK TITAN

Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Xtant Medical Holdings, Inc. (XTNT) CEO to present at TD Cowen 44th Annual Healthcare Conference. The presentation will be on March 4, 2024, at 12:50 p.m. ET in Boston. A live webcast will be accessible on the Company’s website. A replay will be available for 90 days post-presentation.
Positive
  • None.
Negative
  • None.

BELGRADE, Mont., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the TD Cowen 44th Annual Healthcare Conference, to be held on Monday, March 4, 2024 at 12:50 p.m. Eastern Time in Boston.

A live webcast of the presentation will be available on the Investors section of the Company’s website or through the conference site by using the link below:

Date: Monday, March 4, 2024
Time: 12:50 p.m. ET
Webcast: Click Here

A replay of the webcast will be available for approximately 90 days on the Company’s website at www.xtantmedical.com following the conclusion of the presentation.

About Xtant Medical Holdings, Inc.

Xtant Medical’s mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

Investor Relations Contact

David Carey
Lazar FINN Partners
Ph: 212-867-1762
Email: david.carey@finnpartners.com


The CEO of Xtant Medical Holdings, Inc. will present at the TD Cowen 44th Annual Healthcare Conference on March 4, 2024.

The presentation will be held in Boston.

Investors can access the live webcast on the Investors section of the Company’s website or through the conference site.

The replay of the webcast will be available for approximately 90 days on the Company’s website.
Xtant Medical Holdings Inc

NYSE:XTNT

XTNT Rankings

XTNT Latest News

XTNT Stock Data

Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
Health Technology, Medical Specialties, Manufacturing, Biological Product (except Diagnostic) Manufacturing
US
Belgrade

About XTNT

xtant medical (nyse mkt: xtnt) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. with core competencies in both biologic and non-biologic surgical technologies, xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets. for further information, please visit xtantmedical.com.